Multiple Sclerosis

What is Multiple Sclerosis?

Multiple sclerosis (MS) is an autoimmune condition in which the body's immune system mistakenly attacks myelin — the protective coating around nerve fibres in the central nervous system. This disrupts or blocks the nerve signals that travel between the brain, spinal cord, and the rest of the body. The resulting symptoms depend on which nerves are affected.

MS is one of the most common neurological conditions affecting young adults, typically diagnosed between ages 20 and 50, with women diagnosed approximately three times more often than men. Around 2.8 million people worldwide live with MS.

Types of MS:

• Relapsing-remitting MS (RRMS) — the most common type (about 85% of diagnoses); characterised by episodes ("relapses") of new or worsening symptoms, followed by periods of partial or complete recovery
• Secondary progressive MS (SPMS) — many people with RRMS eventually transition to SPMS, where symptoms gradually worsen with fewer distinct relapses
• Primary progressive MS (PPMS) — characterised by gradual worsening from the onset without distinct relapses; less common
• Progressive relapsing MS (PRMS) — rare; gradual progression with clear relapses

How It Presents

MS is highly variable. Symptoms can include:

• Fatigue — one of the most common and disabling symptoms; distinct from ordinary tiredness
• Mobility difficulties — weakness, spasticity, coordination problems, and balance issues
• Visual disturbances — optic neuritis (inflammation of the optic nerve) causing pain and blurred or double vision
• Cognitive changes — difficulties with memory, processing speed, and concentration ("cog fog")
• Sensory symptoms — numbness, tingling, pain
• Bladder and bowel dysfunction
• Heat sensitivity — symptoms worsen with increased body temperature (Uhthoff's phenomenon)
• Depression and anxiety

The episodic nature of relapsing MS means that functional needs can change dramatically. A person may need a wheelchair during a relapse and not need one between episodes.

Assistive Technology

• Mobility aids — canes, walkers, scooters, and wheelchairs (needs may be episodic)
• Fatigue management tools — scheduling apps, energy conservation strategies
• Cognitive aids — reminder apps, calendar systems, and note-taking tools for "cog fog"
• Voice control — reduces physical demands of computing during periods of hand weakness or tremor
• Cooling vests and devices — help manage heat sensitivity
• Screen readers and magnification — for those with vision involvement
• Environmental modifications — grab rails, stairlifts, and accessible home design

Common Misconceptions

• "MS always leads to a wheelchair." The majority of people with MS do not use wheelchairs within the first 15–20 years of diagnosis. MS progression is highly variable.
• "MS is fatal." MS is rarely directly fatal. Life expectancy is close to that of the general population, though quality of life varies.
• "If someone looks fine, their MS is not that bad." Fatigue, cognitive fog, pain, and other invisible symptoms can be severely disabling even when someone appears well.

Language and Identity

Person-first language ("person with MS") is the most common approach. The MS community includes strong self-advocacy voices, and many people with MS identify with the broader disability rights movement — particularly around the social and environmental barriers that compound the functional impacts of the condition.